ZA200904917B - Ophthalmic compositions containing a synergistic combination of three polymers - Google Patents

Ophthalmic compositions containing a synergistic combination of three polymers

Info

Publication number
ZA200904917B
ZA200904917B ZA200904917A ZA200904917A ZA200904917B ZA 200904917 B ZA200904917 B ZA 200904917B ZA 200904917 A ZA200904917 A ZA 200904917A ZA 200904917 A ZA200904917 A ZA 200904917A ZA 200904917 B ZA200904917 B ZA 200904917B
Authority
ZA
South Africa
Prior art keywords
polymers
compositions containing
synergistic combination
ophthalmic compositions
ophthalmic
Prior art date
Application number
ZA200904917A
Other languages
English (en)
Inventor
Masood A Chowhan
Huagang Chen
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of ZA200904917B publication Critical patent/ZA200904917B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200904917A 2007-02-09 2008-02-08 Ophthalmic compositions containing a synergistic combination of three polymers ZA200904917B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88897507P 2007-02-09 2007-02-09

Publications (1)

Publication Number Publication Date
ZA200904917B true ZA200904917B (en) 2010-09-29

Family

ID=39402554

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904917A ZA200904917B (en) 2007-02-09 2008-02-08 Ophthalmic compositions containing a synergistic combination of three polymers

Country Status (13)

Country Link
US (1) US20080193407A1 (xx)
EP (1) EP2109442B1 (xx)
JP (2) JP5431965B2 (xx)
KR (1) KR101555291B1 (xx)
CN (1) CN101605531B (xx)
AU (1) AU2008216497B2 (xx)
BR (1) BRPI0806967A2 (xx)
CA (1) CA2675601C (xx)
ES (1) ES2460570T3 (xx)
MX (1) MX2009007774A (xx)
PL (1) PL2109442T3 (xx)
WO (1) WO2008100807A2 (xx)
ZA (1) ZA200904917B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2839898C (en) * 2003-06-13 2017-01-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US20100104654A1 (en) * 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
US9636355B2 (en) * 2011-09-22 2017-05-02 Theo Holdings, Llc Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
UA113434C2 (xx) * 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
DE102014007423A1 (de) * 2014-05-22 2015-11-26 Bitop Ag Zusammensetzung zur Behandlung des Auges
RU2576778C1 (ru) * 2015-02-20 2016-03-10 Илья Александрович Марков Фармацевтическая композиция в виде гелеобразных глазных капель для лечения глаукомы
KR20190003997A (ko) * 2016-06-01 2019-01-10 해롤드 리차드 헬스트롬 부교감 신경제와 항교감 신경제를 이용한 안구 건조증의 치료
US20180098937A1 (en) * 2016-10-12 2018-04-12 Ps Therapies Ltd Artificial tear, contact lens and drug vehicle compositions and methods of use thereof
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
KR102051356B1 (ko) * 2019-01-03 2019-12-03 (주)휴온스 고농도의 히알루론산 또는 그의 염을 함유하는 점안 조성물
TWI826685B (zh) 2019-05-02 2023-12-21 瑞士商愛爾康公司 可溶解聚合物眼睛插入物及其使用方法
BE1030504B1 (fr) * 2022-05-06 2023-12-04 Eyed Pharma Insert composite pour le traitement de la sécheresse oculaire
WO2023214027A1 (en) * 2022-05-06 2023-11-09 Eyed Pharma Insert for the treatment of dry eyes
BE1030503B1 (fr) * 2022-05-06 2023-12-04 Eyed Pharma Insert pour le traitement de la sécheresse oculaire
WO2024180472A1 (en) * 2023-02-28 2024-09-06 Alcon Inc. Ocular inserts
WO2024180453A1 (en) * 2023-02-28 2024-09-06 Alcon Inc. Dissolvable polymeric eye inserts with a non-ionic cellulose derivative

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3355336A (en) * 1966-08-18 1967-11-28 Du Pont Thickened water-bearing inorganic oxidizer salt explosive containing crosslinked galactomannan and polyacrylamide
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
US4039662A (en) * 1975-12-04 1977-08-02 Alcon Laboratories, Inc. Ophthalmic solution
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4767463A (en) * 1987-04-15 1988-08-30 Union Carbide Corporation Glycosaminoglycan and cationic polymer combinations
US5368843A (en) * 1988-06-08 1994-11-29 Lever Brothers Company, Division Of Conopco, Inc. Thickening system
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
CA2134376C (en) * 1993-12-20 2001-10-23 Haresh G. Bhagat Combinations of polymers for use in physiological tear compositions
EP0686393B1 (en) * 1994-03-18 1998-05-20 Senju Pharmaceutical Co., Ltd. Ophthalmic preparations containing sarpogrelate for reducing intraocular pressure
US5939485A (en) * 1995-06-19 1999-08-17 Medlogic Global Corporation Responsive polymer networks and methods of their use
PT970175E (pt) * 1997-07-29 2003-02-28 Alcon Lab Inc Solucoes de acondicionamento para cuidar de lentes de contacto rigidas
CA2296080C (en) * 1997-07-29 2005-02-01 Alcon Laboratories, Inc. Ophthalmic compositions containing galactomannan polymers and borate
US7001615B1 (en) * 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
TW200400055A (en) * 2002-02-22 2004-01-01 Pharmacia Corp Ophthalmic formulation with novel gum composition
US20050013854A1 (en) * 2003-04-09 2005-01-20 Mannino Raphael J. Novel encochleation methods, cochleates and methods of use
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7914803B2 (en) * 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
CA2839898C (en) * 2003-06-13 2017-01-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers

Also Published As

Publication number Publication date
EP2109442A2 (en) 2009-10-21
CA2675601A1 (en) 2008-08-21
KR20090108092A (ko) 2009-10-14
US20080193407A1 (en) 2008-08-14
KR101555291B1 (ko) 2015-09-30
CN101605531A (zh) 2009-12-16
AU2008216497B2 (en) 2013-09-26
AU2008216497A1 (en) 2008-08-21
JP2010518116A (ja) 2010-05-27
WO2008100807A2 (en) 2008-08-21
MX2009007774A (es) 2009-07-31
ES2460570T3 (es) 2014-05-13
PL2109442T3 (pl) 2014-07-31
JP2014040474A (ja) 2014-03-06
JP5431965B2 (ja) 2014-03-05
CN101605531B (zh) 2012-10-10
WO2008100807A3 (en) 2008-12-24
EP2109442B1 (en) 2014-03-26
CA2675601C (en) 2016-06-21
BRPI0806967A2 (pt) 2014-04-08

Similar Documents

Publication Publication Date Title
ZA200904917B (en) Ophthalmic compositions containing a synergistic combination of three polymers
HK1253355A1 (zh) 含有馬西替坦的治療組合物
EP2073632A4 (en) SYNERGISTIC COMPOSITIONS FOR THE CONTROL OF HARMFUL ANIMALS
EP2219637A4 (en) AVENANTHRAMIDE COMPOSITIONS
IL199656A0 (en) Tablet-in-tablet compositions
GB0724342D0 (en) Anitbacterial compositions
HUE059171T2 (hu) Kompozíciók
HK1146900A1 (en) Ophthalmic composition
GB0711683D0 (en) Compositions
GB0712024D0 (en) Compositions
EP2182811A4 (en) ANTIMICROBIAL COMPOSITIONS
EP2197449A4 (en) NOVEL OPHTHALMIC COMPOSITIONS
GB0808835D0 (en) Therapeutic compositions
IL197235A0 (en) Therapeutic compositions
GB2456407B (en) Polymer compositions
EP2191007A4 (en) HYDROGEL COMPOSITIONS
GB0819958D0 (en) Therapeutic compositions
EP2197452A4 (en) DHEA INHALATION COMPOSITIONS
EP2170081A4 (en) ANTIMICROBIAL COMPOSITIONS
EP2043628A4 (en) ULTRAVIOLET ABSORBENT OPHTHALMIC COMPOSITIONS
EP2214697A4 (en) COMPOSITIONS OF NELL-1
GB0710144D0 (en) Therapeutic compositions
PL381890A3 (pl) Osłona oczu
ZA201006349B (en) Synergistic herbicide composition
GB0708492D0 (en) Compositions